Similar Items: Pathogenic germline variants identified in pNEN patients during genetic testing
- Women’s health across the reproductive lifespan in women with germline TP53 pathogenic variants: a clinical perspective
- Advancing Germline Genetic Testing for Breast Cancer in Resource-Restricted Settings: Evidence, Barriers, and a Practical Roadmap for Implementation
- Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): a phase II study (NIRA-PANC)
- Clinical implications of variant allele frequencies of genes in patients with acute myeloid leukemia
- Genetic testing for cancer predisposition syndromes in pediatric cancer patients: current practices and recommendations - a systematic review
- Genetic correlations and clinical value of increased renal echogenicity in fetuses identified by prenatal ultrasonography